Test Name: Comprehensive Myeloid Sequencing Panel
Methodology: Molecular Genetics
The TruSight Myeloid Sequencing Panel uses next-generation sequencing (NGS) technology to provide a comprehensive assessment of 54 genes (tumor suppressor genes and oncogenic hotspots) to target mutations with known involvement in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), chronic myelogenous leukemia (CML), chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).
•Peripheral blood: 4 mL in EDTA tube.
•Bone marrow: 2 mL in EDTA tube.
Storage and Transport
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. Ship same day as drawn whenever possible; specimens <72 hours old preferred.
Specimen Rejection Criteria
Turn Around Time (TAT): 7-10 Days
CPT Codes*: 81455
*The CPT codes provided with our Test Descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.